Latest Articles
-
A Look At Abbott’s Vascular Division
Abbott Labs (NYSE:ABT) is one of the largest healthcare firms in the U.S. It spun off its proprietary pharmaceutical division as Abbvie (NYSE:ABBV) earlier this year and is now left with four main business divisions – Nutritionals, Diagnostics, V...
-
New Products Drive Medtronic’s Q2 2014 Results
Medtronic Inc. (NYSE:MDT) reported its fiscal Q2 2014 earnings on November 19. The company reported an operational growth of 3.3%, in line with management’s full-year guidance and slightly better than last quarter’s performance. The growth rate i...
-
Medtronic Earnings Preview: Cardiac Rhythm Management In Focus
Medtronic (NYSE:MDT) is scheduled to release its Q2 fiscal 2014 earnings on November 19. Last quarter, the company reported operational sales growth of 3%, at the lower end of its guidance of 3%-4% for fiscal 2014. The operational growth figure ...
-
Boston Scientific Earnings: Key Businesses Stabilizing, More Cost Cutting To Come
Boston Scientific (NYSE:BSX) released its earnings for Q3 on October 24. The company’s results reflect the same story that has played out so far this year – its smaller divisions are growing fast, while two of its largest divisions, Cardiac Rhyth...
-
Boston Scientific Earnings Preview: New Products and Margins In Focus
Boston Scientific (NYSE:BSX) is scheduled to release its earnings for Q3 2013 on October 24. The medical device maker’s revenue has been declining since 2009 due to increased competition and pricing pressures. However, it has been rebuilding its ...
-
Biotech Merger And Acquisition Rumors And News
Submitted by Scott Matusow as part of our contributors program . Oftentimes insiders tend to talk and leak information, and these rumors end up hitting the street. However, there is no way to know for sure since I am not an insider and have n...
-
3 Low Valued Healthcare Stocks With Massive Possibilities To Boost Dividends
Submitted by Dividend Yield as part of our contributors program . Healthcare dividend stocks with low payout ratios and small debt figures originally published at long-term-investments.blogspot.com . I love the combination of low debt with l...
-
AcelRx May Be In Play For Acquisition Soon: NDA To Be Filed At Month’s End
Submitted by Scott Matusow as part of our contributors program . We believe that AcelRx Pharmaceuticals (NASDAQ: ACRX) warrants a close look by both longer-term investors and shorter-term catalyst traders. We have been hearing some strong...
-
Medtronic Maintains Its Growth Despite Weak Defibrillators Sales
Medtronic (NYSE:MDT) announced its Q1 earnings for fiscal 2014 on August 20. The company registered 3% operational growth in total revenues to $4.08 billion. While the overall growth was mostly in line with our expectations, what came as a little...
-
4 Of The Biggest Stocks With Recent Dividend Growth
Submitted by Dividend Yield as part of our contributors program . Stocks with dividend hikes from last week originally published at long-term-investments.blogspot.com . Dividend growth matters and has significant influence to your asset strate...
-
Medtronic Q1 Earnings Preview: Growth Momentum Picking Up
Medtronic (NYSE:MDT) is set to announce its Q1 fiscal 2014 earnings on August 20, where we expect it to post mid-single digit growth. Its key pacemakers & defibrillators business, which was a major drag on revenue growth for the last two year...
-
20 Dividend Champions With Highest YTD Performance And Still Low P/E’s
Submitted by Dividend Yield as part of our contributors program . Dividend Champions with highest performance year-to-date originally published at “ long-term-investments.blogspot.com “. Around 104 stocks from the American capital ...
-
4 Healthcare Dividend Stocks With Single Price/Earning Ratios And 20%+ Performance
Submitted by Dividend Yield as part of our contributors program . Healthcare dividend stocks with the highest year-to-date performance originally published at “ long-term-investments.blogspot.com “. We’ve completed the month ...
-
Medtronic: Independent Review Raises Doubts On Benefits Of Infuse Bone Graft
Yale University has completed an independent review of Medtronic’s (NYSE:MDT) Infuse bone graft and two independent analyses have suggested that it doesn’t show significant benefits over conventional spine surgery. Worse, it may lead ...
-
19 Latest Stocks With Dividend Growth And Which To Consider
Submitted by Dividend Yield as part of our contributors program . Stocks with dividend hikes from last week originally published at “ long-term-investments.blogspot.com “. I enjoy it really to see how dividends grow. One company wi...
